GenePath Diagnostics operates a state-of-the-art lab and R&D facility in Pune, India as well as an R&D lab in Ann Arbor, Michigan. We are an innovation-centric company with a strong emphasis on continuous R&D, and working closely with clinicians to develop affordable, high quality and scalable solutions. Examples include creating one of the world’s most efficient genetic tests for population screening of Spinal Muscular Atrophy (SMA), building a high quality and affordable solution for chronic myeloid leukemia (BCR-ABL) and now building one of the most sensitive and specific tests for COVID-19. We are a unique company in that we are both an advanced R&D team as well as a cutting edge lab, thereby allowing rapid feedback between the two steps, to create truly world class products and services.

In early 2021 we launched GeneClinicX, our preventive healthcare division that offers personalised and data driven healthcare programs that focus on heart health, weight loss, and reducing the risk of Type 2 diabetes or better managing the condition, if already present. Our approach is scientific, data driven and real-time, leveraging the best in modern medical technology. Our cross-disciplinary team of dietitians, geneticists and doctors create medically valid solutions personalized to participant needs, and our solutions are both easy to implement and sustainable, thereby driving long-term success of our programs.

At GenePath, we strongly believe in our culture and our company’s values are the principles and ideals that we live by.